Hedge Funds Made A Bundle By Betting On Amazon.com, Inc. (AMZN), Apple, and Pfizer Inc

Finally, Pfizer Inc. (NYSE:PFE) and China Life Insurance Company Ltd. (ADR) (NYSE:LFC) appreciated by 12.66% and 12.55%, respectively. Pfizer is another biopharmaceutical company, though one that struggled during the fourth quarter, reporting lower sales and earnings. The company’s financial results have been deteriorating for the past several years, in fact, mainly because of the large amount of generic drugs invading the market. However, Pfizer Inc. (NYSE:PFE) has been making up for the lost market share by expanding its portfolio through acquisitions, and it plans to reduce its R&D budget, which will add more value. At the end of 2014, 86 funds held around $4.68 billion worth of Pfizer Inc. (NYSE:PFE)’s stock, including Fisher Asset Management, which owns 31.20 million shares, according to its latest 13F filing.

China Life Insurance Company Ltd. (ADR) (NYSE:LFC) is a $128 billion life insurance company, in which only nine funds reported long positions, which amass less than 1% of their equity portfolios. This low level of popularity is interesting because the stock has had a strong run so far. However, the company has been losing market share, which amounted to 26% last year, versus 30% in 2013. China Life Insurance Company Ltd. (ADR) (NYSE:LFC) is expected to keep losing ground to smaller insurance companies, and despite earnings growth, it has been lagging behind its peers from the region. The largest stake in China Life Insurance Company Ltd. (ADR) (NYSE:LFC) among the funds that we track is held by Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, which owns 1.05 million shares, while other funds hold under 70,000 shares.

Disclosure: None